Xiaokun Li Selected Research

Fibroblast Growth Factors (Fibroblast Growth Factor)

12/2021	FGF/FGFR signaling: From lung development to respiratory diseases.
1/2021	Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice.
1/2020	An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.
1/2018	Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
1/2018	Fibroblast growth factors in the management of spinal cord injury.
7/2017	Increased production of human fibroblast growth factor 17 in Escherichia coli and proliferative activity in NIH3T3 cells.
3/2017	Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats.
1/2017	Acid fibroblast growth factor preserves blood-brain barrier integrity by activating the PI3K-Akt-Rac1 pathway and inhibiting RhoA following traumatic brain injury.
10/2015	Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.
7/2015	Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaokun Li Research Topics

Disease

54	Neoplasms (Cancer) 11/2022 - 10/2007
43	Inflammation (Inflammations) 01/2021 - 12/2009
32	Wounds and Injuries (Trauma) 01/2022 - 03/2005
23	Obesity 10/2022 - 01/2012
22	Fibrosis (Cirrhosis) 07/2021 - 11/2008
22	Insulin Resistance 01/2021 - 02/2011
15	Hyperglycemia 01/2021 - 10/2006
13	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2012
12	Diabetic Nephropathies (Diabetic Nephropathy) 12/2019 - 04/2007
12	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 12/2009
11	Spinal Cord Injuries (Spinal Cord Injury) 10/2021 - 05/2014
11	Diabetic Cardiomyopathies 01/2021 - 10/2006
10	Infections 01/2022 - 02/2014
10	Cognitive Dysfunction 07/2021 - 04/2006
9	Hypertrophy 01/2021 - 07/2010
8	COVID-19 11/2021 - 01/2020
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 09/2012
8	Schizophrenia (Dementia Praecox) 05/2014 - 12/2005
7	Body Weight (Weight, Body) 01/2022 - 01/2012
7	Carcinogenesis 11/2019 - 07/2010
7	Metabolic Diseases (Metabolic Disease) 10/2019 - 02/2010
6	Necrosis 01/2022 - 10/2014
6	Hypoxia (Hypoxemia) 08/2021 - 06/2012
6	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2009
6	Fatty Liver 01/2021 - 08/2015
6	Diabetes Mellitus 01/2019 - 04/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 02/2018 - 11/2014
6	Diabetes Complications 11/2017 - 07/2007
5	Non-alcoholic Fatty Liver Disease 10/2022 - 01/2012
5	Brain Ischemia (Cerebral Ischemia) 07/2022 - 10/2017
5	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2014
5	Cicatrix (Scar) 01/2022 - 01/2008
5	Heart Diseases (Heart Disease) 07/2021 - 01/2013
5	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2011
5	Ischemia 12/2018 - 04/2007
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 10/2014
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2010
4	Adenocarcinoma of Lung 09/2021 - 01/2019
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2010
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2010
4	Cardiomegaly (Heart Hypertrophy) 10/2020 - 01/2016
4	Peripheral Nerve Injuries 01/2020 - 02/2017
4	Crush Injuries 01/2020 - 02/2017
4	Atherosclerosis 06/2015 - 07/2009
4	Proteinuria 01/2014 - 04/2007
3	Starvation 01/2022 - 10/2015

Drug/Important Bio-Agent (IBA)

52	fibroblast growth factor 21IBA 07/2022 - 02/2010
43	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2006
23	Pharmaceutical PreparationsIBA 11/2022 - 07/2008
20	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 02/2011
19	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2021 - 07/2007
18	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2021 - 04/2007
17	LipidsIBA 01/2021 - 12/2010
17	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2008
13	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2021 - 01/2010
10	Insulin (Novolin)FDA Link 01/2021 - 12/2010
10	Neuroprotective AgentsIBA 01/2021 - 09/2006
10	HydrogelsIBA 01/2020 - 07/2016
9	Messenger RNA (mRNA)IBA 12/2022 - 01/2010
9	Hormones (Hormone)IBA 01/2022 - 05/2013
9	Phosphotransferases (Kinase)IBA 01/2021 - 01/2010
9	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2016
9	Peptides (Polypeptides)IBA 10/2016 - 05/2009
8	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 10/2013
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 03/2005
8	Angiotensin IIIBA 07/2021 - 07/2011
8	CurcuminIBA 01/2015 - 03/2009
7	CollagenIBA 01/2022 - 01/2008
7	Nerve Growth Factor (NGF)IBA 10/2021 - 05/2014
7	Therapeutic UsesIBA 01/2020 - 01/2006
7	LigandsIBA 01/2020 - 08/2011
6	CytokinesIBA 01/2022 - 07/2012
6	Biomarkers (Surrogate Marker)IBA 04/2021 - 05/2014
6	AlbuminsIBA 01/2021 - 04/2011
6	AntioxidantsIBA 01/2021 - 10/2006
6	Biological ProductsIBA 01/2021 - 05/2010
6	ErbB Receptors (EGF Receptor)IBA 01/2019 - 03/2016
6	Quetiapine Fumarate (Seroquel)FDA Link 08/2009 - 12/2005
6	Antipsychotic Agents (Antipsychotics)IBA 08/2009 - 01/2006
5	Long Noncoding RNAIBA 09/2021 - 01/2019
5	ApolipoproteinsIBA 01/2021 - 12/2010
5	Blood Glucose (Blood Sugar)IBA 01/2021 - 12/2010
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2010
5	Poloxamer (Poloxamer 407)IBA 01/2020 - 03/2017
5	Caspase 3 (Caspase-3)IBA 01/2019 - 10/2006
5	CreatinineIBA 01/2019 - 04/2011
5	AdiponectinIBA 05/2015 - 04/2011
5	MetallothioneinIBA 06/2012 - 10/2006
4	Protein Isoforms (Isoforms)IBA 01/2022 - 04/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 07/2012
4	Fibroblast Growth Factor 10IBA 01/2021 - 10/2017
4	Epidermal Growth Factor (EGF)IBA 08/2018 - 07/2007
4	Palmitic Acid (Hexadecanoic Acid)IBA 01/2018 - 01/2016
4	CXC ChemokinesIBA 09/2017 - 08/2011
4	EnzymesIBA 01/2017 - 01/2010
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2016 - 07/2007
4	Adenosine Triphosphate (ATP)IBA 04/2015 - 03/2014
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022 - 01/2019

Therapy/Procedure

32	Therapeutics 11/2022 - 10/2007
4	Oral Administration 01/2019 - 01/2015